Abstract-Patients with progressive nonfluent aphasia (PNFA) can become mute early in the course of the disease. Voxel-based morphometry showed that PNFA is associated with left anterior insula and inferior frontal atrophy. In PNFA with early mutism, volume loss was more prominent in the pars opercularis and extended into the left basal ganglia. Damage to the network of brain regions involved in both coordination and execution of speech causes mutism in PNFA. NEUROLOGY 2006;67:1849-1851 M.L. Gorno-Tempini, MD, PhD; J.M. Ogar, MS; S.M. Brambati, PhD; P. Wang, MD; J.H. Jeong, MD; K.P. Rankin, PhD; N.F. Dronkers, PhD; and B.L. Miller, MD Primary progressive aphasia (PPA) is characterized by speech and language deficits that remain isolated for at least 2 years. 1 Once thought a unitary syndrome, PPA is now typically divided into variants.
Primary progressive aphasia (PPA) is characterized by speech and language deficits that remain isolated for at least 2 years. 1 Once thought a unitary syndrome, PPA is now typically divided into variants. 2, 3 . Progressive nonfluent aphasia (PNFA) is characterized by effortful speech, agrammatism in production and comprehension, with preserved single word comprehension. It has been shown that apraxia of speech (AOS) is the most common motor speech deficit in PNFA. 2 "Mutism," resulting from AOS or dysarthria, is the absence of speech or articulatory movement and can occur with neurologic disturbances, including Parkinson disease, ALS, progressive supranuclear palsy (PSP), and frontotemporal dementia. 4 Whereas mutism typically occurs at the end stage of dementia of any cause, in PNFA, patients can become functionally mute early in the disease course, while other cognitive functions are spared.
Previous studies consistently indicate the left posterior inferior frontal (operculum) and anterior insular regions as the crucial sites of anatomic damage in PNFA. 2, 5 However, the anatomic basis of early mutism in these disorders is not known.
We used voxel-based morphometry (VBM) to compare patterns of gray matter atrophy between patients with PNFA who developed mutism early in the disease, non-mute patients with PNFA, and normal control subjects. We sought to identify which brain regions are associated with early complete loss of speech in PNFA.
Methods. Subjects and cognitive data. Six mute patients (five women, one man) were selected from a pool of patients with PNFA at the University of California (UCSF) Memory and Aging Center, along with five other non-mute patients with PNFA (all women), who presented with speech deficits of varying severity. The two groups were matched for disease duration. PNFA was diagnosed based on clinical history, neurologic examination, neuropsychological screening, neuroimaging findings, and speech and language evaluation (table). Specifically, patients presented with a motor speech impairment and at least one of the following: agrammatism in language production; spared single-word comprehension and impaired comprehension of complex syntactic structures (table). A diagnosis of "functional mutism" was made if the patient was unable to speak a single intelligible word owing to motor speech impairment. All mute patients also demonstrated severe buccofacial apraxia, and one had mild swallowing troubles. Three of the five non-mute patients also showed buccofacial apraxia.
Forty age-and sex-matched healthy subjects, with no history of neurologic or psychiatric disease, were used as controls for the VBM analysis (mean age: 65.1; 6 men, 34 women). Ten age-and sex-matched healthy subjects were used as a control group for the cognitive data when normative data were not available (table). Group differences were determined using the Mann-Whitney U test. PNFA-mute patients were older than the PNFA non-mute group (p Ͻ 0.02); however, disease duration did not significantly differ, nor did education or female-to-male ratio.
MRI scanning and VBM. MRI scans were obtained on a 1.5-T Magnetom VISION system (Siemens Inc., Iselin, N.J.). A volumetric magnetization prepared rapid gradient echo MRI (MPRAGE) sequence was used to obtain T1-weighted images of the entire brain, with 1.0 ϫ 1.0 mm 2 in-plane resolution and 1.5 mm slab thickness. All scans were acquired within a 6-month period from the time of clinical evaluation.
We compared gray matter regional volumes in the two groups of patients with PNFA (mute and non-mute) using VBM standard technique implemented in the SPM2 software package. 6 Ad-hoc age-matched a priori and template images were created. Age, gender, and total intracranial volume were entered into the design matrix as nuisance variables.
We performed specific statistical analyses to investigate the regions of common atrophy in PNFA-mute and PNFA-non-mute vs controls and the group differences between the two patient popu-lations using the inclusive masking procedure. We accepted a statistical threshold of p Ͻ 0.05 corrected for multiple comparisons for the main contrasts and of p Ͻ 0.001 uncorrected for the contrasts used as masks. Based on previous work, the left inferior frontal gyrus, anterior insula, and basal ganglia were considered a priori regions of interest.
Results. Common atrophy in non-mute and mute.
The left inferior frontal gyrus pars opercularis, insula, superior temporal gyrus, and precentral regions were atrophied in mute and non-mute patients. As shown in the figure (A through C) and table E-1 on the Neurology Web site (www.neurology.org), the medial portion of the operculum and the anterior insula regions were included in the same cluster and, with a 12-mm smoothing kernel, it was difficult to establish which of the two regions was more involved. The peak coordinate (Ϫ46, 13, 4) is centered in the medial portion of the frontal operculum; at a lower threshold, the cluster extends medially and assumes the shape of the insula. This region was significantly atrophied in both groups but showed greater volume loss in the mute group.
Greater atrophy in mute vs non-mute and control subjects. In the mute group, atrophy was more significant and encompassed a larger and more lateral portion of the left inferior frontal gyrus, extending further laterally in the pars opercularis (p Ͻ 0.05 corrected for multiple comparison) (figure; table E-2). At a lower threshold of p Ͻ 0.001 uncorrected, atrophy also extended to the left basal ganglia and to the pars orbitalis.
Discussion. We sought to delineate which brain regions show greater atrophy in mute patients with PNFA compared to patients with PNFA and milder articulation deficits. In all patients with PNFA, significant atrophy was found in brain regions supporting speech production, specifically the left inferior frontal gyrus, insula, and superior temporal gyrus. In the six mute patients with PNFA, however, damage to this network was more extensive, with greater atrophy noted in the left pars opercularis of the inferior frontal gyrus (posterior portion of Broca area). Atrophy in the mute cohort also extended subcortically into the left basal ganglia and thalamus and anteriorly and ventrally to the orbitofrontal region.
The inferior frontal and insular regions areas atrophied in all patients with PNFA are recognized as important for generating speech. 7, 8 In the mute patients, atrophy was more significant and more extensive in the lateral portion of the pars opercularis of Broca area and extended medially to encompass the basal ganglia. Our results support roles for the anterior insula and inferior frontal gyrus in speech production, most probably in coordinating and planning movements for speech articulation. However, significant damage to the lateral portion of the frontal operculum appears to be critical for causing complete loss of speech in PNFA, most likely by supporting the final execution stages of speech production. Furthermore, in the mute group, atrophy also encompassed the basal ganglia, although at a lower level of significance. The basal ganglia are thought to play a critical role in generating motor programs for speech. 9 Therefore, in PNFA, mutism occurs when damage to the speech production network reaches a critical point, involving both cortical and subcortical motor speech mechanisms.
The pattern of anatomic damage suggests that the PFA non-mute and mute groups represent two stages or two presentations of the same disease. Clinical and neuropathologic data imply that corticobasal degeneration (CBD) and PSP are the most common clinical evolution and pathologic diagnosis in PNFA. 5, 10 This is especially true for cases in which progressive speech disorder is the most salient symptom. 
